Literature DB >> 26885099

Risk factors associated with diabetic retinopathy onset and progression in diabetes patients: a Taiwanese cohort study.

Shih-Ting Tseng1, Su-Tze Chou2, Boon-Hua Low3, Feng-Lin Su3.   

Abstract

Diabetic retinopathy (DR) is a common complication of type 2 diabetes mellitus (T2DM) and the leading cause of adult blindness. This study aimed to clarify the risk factors associated with DR onset and progression in patients with T2DM in Taiwan. This retrospective analysis enrolled 743 T2DM patients, including 170 with DR and 573 without DR at baseline who were enrolled in the Diabetes Shared-Care Program. The average follow-up period was 2.9 years. Variables, including demographic characteristics, DM duration, anthropometric data and clinical laboratory results, were compared between patients with DR at baseline, those with new-onset DR, and patients without DR using a chi-squared test and one-way ANOVA. A multivariate Cox proportional hazards model was performed to identify risk factors associated with progression of preexisting DR or new-onset DR. During the follow-up period, 38 (22.4%) patients with preexisting DR experienced disease progression, and 91 (15.9%) patients had new-onset DR. Multivariate analysis revealed that the presence of neuropathy (HR: 3.96, 95% CI: 1.84, 8.53) and diastolic blood pressure (HR: 1.05, 95% CI: 1.02, 1.08) were associated with increased risk of DR progression (both P < 0.001). Factors associated with new-onset DR included neuropathy, systolic BP, cholesterol, and updated mean of HbA1c (all P ≤ 0.001). The risk factors associated with DR onset and progression in Taiwanese patients with T2DM are different. Neuropathy and blood pressure increased the risk of both DR onset and progression; however, the risk of DR onset was also increased with updated mean of HbA1c and cholesterol.

Entities:  

Keywords:  Complications; diabetes mellitus; diabetic retinopathy; glycated hemoglobin; risk factor

Year:  2015        PMID: 26885099      PMCID: PMC4723944     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Age at onset and the risk of proliferative retinopathy in type 1 diabetes.

Authors:  Kustaa Hietala; Valma Harjutsalo; Carol Forsblom; Paula Summanen; Per-Henrik Groop
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

3.  Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009.

Authors:  Yu-Yao Huang; Kun-Der Lin; Yi-Der Jiang; Chia-Hsuin Chang; Ching-Hu Chung; Lee-Ming Chuang; Tong-Yuan Tai; Low-Tone Ho; Shyi-Jang Shin
Journal:  J Formos Med Assoc       Date:  2012-11-26       Impact factor: 3.282

4.  Impact of long-term measures of glucose and blood pressure on the retinal microvasculature.

Authors:  Christy L Avery; Anna Kucharska-Newton; Keri L Monda; A Richey Sharrett; Thomas H Mosley; Barbara E Klein; Mary Frances Cotch; Tien Y Wong; Ronald Klein
Journal:  Atherosclerosis       Date:  2012-10-12       Impact factor: 5.162

5.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

6.  High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration.

Authors:  Shwu-Jiuan Sheu; Ni-Chun Liu; Lu-Ping Ger; Wan-Ling Ho; Jiun-Yo Lin; Shih-Chou Chen; Yu-Harn Horng; Hing-Chung Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-17       Impact factor: 3.117

7.  Predicting development of proliferative diabetic retinopathy.

Authors:  Kristen Harris Nwanyanwu; Nidhi Talwar; Thomas W Gardner; James S Wrobel; William H Herman; Joshua D Stein
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

8.  Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial.

Authors:  Hertzel C Gerstein; Walter T Ambrosius; Ronald Danis; Faramarz Ismail-Beigi; William Cushman; Jorge Calles; Maryann Banerji; Ulrich Schubart; Emily Y Chew
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

9.  A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2008-07-23       Impact factor: 17.152

10.  Impact of changes in metabolic control on progression to photocoagulation for clinically significant macular oedema: a 20 year study of type 1 diabetes.

Authors:  B Sander; M Larsen; E W Andersen; H Lund-Andersen
Journal:  Diabetologia       Date:  2013-08-30       Impact factor: 10.122

View more
  12 in total

Review 1.  The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis.

Authors:  Xiaoling Cai; Yifei Chen; Wenjia Yang; Xueying Gao; Xueyao Han; Linong Ji
Journal:  Endocrine       Date:  2018-08-20       Impact factor: 3.633

2.  MiR-31 is involved in the high glucose-suppressed osteogenic differentiation of human periodontal ligament stem cells by targeting Satb2.

Authors:  Lei Zhen; Xuewei Jiang; Yan Chen; Desheng Fan
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  Salidroside alleviates high-glucose-induced injury in retinal pigment epithelial cell line ARPE-19 by down-regulation of miR-138.

Authors:  Cheng Qian; Shenzhi Liang; Guangming Wan; Yi Dong; Taiying Lu; Panshi Yan
Journal:  RNA Biol       Date:  2019-07-11       Impact factor: 4.652

4.  Development and validation of a model that predicts the risk of diabetic retinopathy in type 2 diabetes mellitus patients.

Authors:  Jing Yang; Sheng Jiang
Journal:  Acta Diabetol       Date:  2022-09-26       Impact factor: 4.087

5.  Evaluation of some oxidative markers in diabetes and diabetic retinopathy.

Authors:  Hadeel Ahmed Shawki; Rasha Elzehery; Maha Shahin; Ekbal M Abo-Hashem; Magdy M Youssef
Journal:  Diabetol Int       Date:  2020-06-27

6.  Associations between alcohol intake and diabetic retinopathy risk: a systematic review and meta-analysis.

Authors:  Chen Chen; Zhaojun Sun; Weigang Xu; Jun Tan; Dan Li; Yiting Wu; Ting Zheng; Derong Peng
Journal:  BMC Endocr Disord       Date:  2020-07-17       Impact factor: 2.763

Review 7.  Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis.

Authors:  Yue Zhou; Changyun Wang; Ke Shi; Xiaolong Yin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

8.  Incidence of diabetes retinopathy and determinants of time to diabetes retinopathy among diabetes patients at Tikur Anbessa Hospital, Ethiopia: a retrospective follow up study.

Authors:  Tabot Keskis Azeze; Malede Mequanent Sisay; Ejigu Gebeye Zeleke
Journal:  BMC Res Notes       Date:  2018-08-02

9.  Hypertension, blood pressure control and diabetic retinopathy in a large population-based study.

Authors:  Lei Liu; Nguyen Duc Quang; Riswana Banu; Himeesh Kumar; Yih-Chung Tham; Ching-Yu Cheng; Tien Yin Wong; Charumathi Sabanayagam
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

10.  Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes.

Authors:  AJin Cho; Hayne Cho Park; Young-Ki Lee; Young Joo Shin; So Hyun Bae; Hakyoung Kim
Journal:  J Diabetes Res       Date:  2020-07-26       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.